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Background—The survival difference between off-pump and on-pump coronary artery bypass
graft (CABG) surgery for follow-up longer than 5 years is not well understood. The objective of
this study is to examine the difference in 7-year mortality after these two procedures.
Methods and Results—New York State’s Cardiac Surgery Reporting System was used to
identify the 2,640 off-pump and 5,940 on-pump isolated CABG patients discharged from July
through December, 2000. The National Death Index was used to ascertain patients’ vital statuses
through 2007. A logistic regression model was fit to predict the probability of receiving an offpump procedure using baseline patient characteristics. Off-pump and on-pump patients were
matched with a 1:1 ratio based on the probability of receiving an off-pump procedure. KaplanMeier survival curves for the 2 procedures were compared using the propensity-matched data, and
the hazard ratio for death for off-pump in comparison to on-pump procedures was obtained. In
subgroup analyses, the significance of interactions between type of surgery and baseline risk
factors was tested. In this study, 2,631 pairs of off-pump and on-pump patients were propensity
matched. The 7-year Kaplan-Meier survival rates were 71.2% and 73.4% (P=0.07) for off-pump
and on-pump surgery, respectively. The hazard ratio for death (off-pump vs. on-pump) was 1.10
(95% confidence interval: 0.99-1.21, P=0.07). No statistical significance was detected for the
interaction terms between type of surgery and a number of different baseline risk factors.
Conclusions—The difference in long-term morality between on-pump and off-pump CABG
surgery is not statistically significant.
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Previous studies have found that off-pump coronary artery bypass graft (CABG) surgery is
more likely to be related to lower rates of graft patency1-4 and complete revascularization2
compared to on-pump CABG surgery. Therefore, off-pump surgery may be related to a
higher rate of repeat revascularization5-7 and mortality in the long run. 8 However, the
relative benefit in long-term survival following off-pump and on-pump CABG surgery has
not been thoroughly studied, and there is limited information on the relative risk of death in
follow-up period of 5 years or more.8
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Using the data of the New York State’s Cardiac Surgery Reporting System (CSRS), we have
examined the differences in mortality for up to 3 years between off-pump and on-pump
CABG surgery.9, 10 However, it is unknown whether the relative survival of the 2 surgical
techniques during longer-term follow-up will be the same as it was observed in these 2
studies. Therefore, the purpose of this study is to examine the difference in 7-year mortality
between off- pump and on-pump CABG surgery.

METHODS
Databases
This study used 2 major databases, the New York State’s CSRS and the National Death
Index (NDI). The CSRS is a state-wide registry that records all major cardiac surgical
procedures performed in nonfederal hospitals in the State of New York. The CSRS has been
in place since 1988, and it is managed by the State’s Department of Health. For each cardiac
surgery case, the discharging hospital collects detailed data on patient demographics, preprocedural risk factors, procedural information, major post-procedural outcomes, and
disposition at discharge. For procedural information, the database includes the utilization of
cardiopulmonary bypass and the conversion of off-pump to on-pump surgery. The cardiac
procedures submitted to the CSRS are matched to the State’s statewide hospital discharge
data to ensure the completeness of case reporting. In addition, samples of the medical
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 10.
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records for reported cases are reviewed periodically by the State’s utilization review
organization to ensure the accuracy of the risk factors. The CSRS was used to identify the
study population and to obtain baseline patient characteristics.
The NDI is managed by the National Center for Health Statistics. This database includes all
death records in the United Sates. In this study, the NDI was used to determine patients’
vital statuses using patients’ social security numbers collected in the CSRS.
Study Population and Outcome
From the CSRS data, a total of 8,580 patients were identified as having undergone isolated
CABG surgery with sternotomy and discharged between July 1 and December 31, 2000. The
patients were classified as off-pump or on-pump patients based on the intent to treat. A total
of 2,640 patients were initially treated by off-pump procedures, and 5,940 patients were
initially treated by on-pump procedures. Among the 2,640 off-pump patients, conversions to
on-pump surgery occurred in 43 (1.6%) patients. These 43 converted patients were treated as
off-pump cases in the main analyses, but a sensitivity analysis was conducted with them in
the on-pump group.
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The outcome of interest in this study is mortality following surgery. The vital status of each
patient was tracked from the date of surgery to December 31, 2007 using the NDI data.
Every patient was followed for at least 7 years or until time of death, and the median length
of follow-up was 7.2 years with an interquartile range of 7.0 - 7.4 years.
Statistical Analysis
First, the differences in baseline patient characteristics in the off-pump and on-pump patients
were examined. The patient characteristics examined included age, sex, race and ethnicity,
body surface area, body mass index (BMI), left main coronary artery disease (stenosis ≥
50%), disease (stenosis ≥ 70%) of the 3 major epicardial coronary arteries, ejection fraction,
history of myocardial infarction, hemodynamic state, various comorbidities, and history of
coronary CABG surgery and percutaneuous coronary intervention (PCI). The differences in
the prevalences of categorical baseline risk factors between off-pump and on-pump patients
were examined using Pearson’s chi-square test, and the means of continuous variables in the
2 groups of patients were compared using Student’s t-test.
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Next, propensity matching was conducted to balance the distribution of patient baseline
characteristics between the off-pump and on-pump patients in order to control for potential
treatment selection bias because of the non-randomized nature of this observational
study.11, 12 The first step in the matching process was to fit a logistic regression model, i.e.,
a propensity model, which included all baseline risk factors as predictors of receiving offpump surgery. This model was then used to calculate each patient’s probability of receiving
off-pump surgery. The log-odds of this probability is the propensity score. Then the offpump and on-pump patients were matched to each other at a 1:1 ratio on the closeness of
propensity scores. For a matched pair, the difference in propensity scores had to be no more
than 0.6 times the standard deviation of the propensity score.13 To evaluate whether the
baseline risk factors were well-balanced, the standardized differences between the 2
matched groups in the prevalences of risk factors examined. A standardized difference less
than 10% for a risk factor is usually viewed as evidence that it was well balanced between
the 2 treatment groups.
Using data from the pair-matched patients, the difference in survival between off-pump and
on-pump surgery was examined using Kaplan-Meier survival analysis with a test suggested
by Klein and Moeschberger.14, 15 The hazard ratio for death for off-pump surgery in
comparison to on-pump surgery was obtained from a Cox proportional hazards regression
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 10.
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model with a robust sandwich estimator to account for the correlations within matched pairs
that modeled the time to event (death) after the procedure using type of surgery as the single
independent variable.16, 17
In addition, subgroup analyses were conducted to evaluate whether the relative risk of death
following off-pump and on-pump surgery was dependent on the presence of certain preselected baseline risk factors (age, sex, left main coronary disease, number of diseased
coronary vessels, ejection fraction, history of myocardial infarction, cerebrovascular disease,
peripheral arterial disease, congestive heart failure, and diabetes). The significance of the
interaction between a given risk factor and type of surgery was tested by fitting a Cox
proportional hazards regression model with a robust sandwich estimator, in which the
independent variables were type of surgery, the risk factor being examined, their interaction
term, and other significant (P<0.05) baseline risk factors for death identified using a
backwards selection approach.
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A sensitivity analysis was conducted considering the possible impact of surgeons’
experience on relative survival after off-pump and on-pump surgery. The risk-adjusted risks
of the death between the 2 procedures were compared in a subset of matched patients, which
consisted of 1,265 off-pump patients operated on by high-volume surgeons (upper quartile)
who performed off-pump surgery in > 50% of their isolated CABG surgery cases and 1,137
on-pump patients operated on by high-volume surgeons who performed on-pump surgery in
> 50% of their isolated CABG surgery cases.
All statistical analyses were conducted in SAS version 9.2 (SAS Institute, Cary, NC).

RESULTS
Table 1 presents the prevalences (means for continuous variables) of baseline risk factors in
the 2,640 off-pump and 5,940 on-pump patients. The off-pump patients were slightly older,
were more likely to have comorbidities such as cerebrovascular disease, peripheral arterial
disease, left ventricular hypertrophy, congestive heart failure, extensively calcified
ascending aorta, and renal failure, have a history of open heart surgery and percutaneous
coronary intervention. The on-pump patients were slightly more likely to be Hispanic, have
slightly larger body surface areas, be overweight or obese, have left main coronary disease
and three-vessel disease, have a history of myocardial infarction within 7 days, have
undergone cardiopulmonary resuscitation prior to surgery, have chronic obstructive
pulmonary disease, and have been transferred as emergency patients to the operating room
after diagnostic catheterization. Also, the mean number of anastomoses was higher for onpump patients (3.34 vs. 2.69, P<0.001).
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A total of 2,631 (99.7%) off-pump patients were pair-matched to on-pump patients. Table 2
shows that the distributions of baseline risk factors between the matched off-pump and onpump patients were well balanced (all P values ≥ 0.25). The standardized differences in
prevalences or means of all risk factors were ≤ 4.3%.
Among the 2,631 pair-matched patients, 48 (1.82%) off-pump and 70 (2.66%) on-pump
patients died within 30 days following surgery. The hazard ratio (HR) for death within 30
days for off-pump in comparison to on-pump surgery was 0.68 (95% confidence interval
(CI): 0.47-0.98), and it was marginally significant (P=0.04). During the follow-up until
December 31, 2007, 782 off-pump and 725 on-pump patients died, and HR for death was
1.10 (95% CI: 0.99-1.21, P=0.07). The Figure shows that the respective 7-year survival rates
for off-pump and on-pump surgery were 73.4% and 71.2% (P=0.07). In a sensitivity analysis
in which the patients who were converted from off-pump to on-pump were regarded as onpump patients, the hazard ratio for death within 30 days was 0.49 (95% CI: 0.33-0.72;
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 10.
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P<0.001), and the hazard ratio for death during the entire follow-up period was 1.10 (95%
CI: 0.99-1.21, P=0.08).
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Table 3 shows that the adjusted HRs ranges from 0.94 to 1.21 across all subgroups. The risk
of death was significantly higher for off-pump surgery in patients who had ejection fractions
of at least 40% (adjusted HR=1.18, P=0.01), and was marginally significant in females
(adjusted HR = 1.21, P=0.04), patients who had multivessel disease (adjusted HR=1.13,
P=0.03), and patients with no congestive heart failure (adjusted HR=1.16, P=0.03). But, all
interaction term between surgery type and all examined risk factors were not statistically
significant (P>0.05). Therefore there was no conclusive evidence that the relative risk of
death following off-pump and on-pump surgery was dependent on the presence of a
particular risk factor.
In the sensitivity analysis that included the 1,265 off-pump patients treated by high-volume
surgeons who performed off-pump surgery in > 50% of their cases and 1,137 on-pump
patients treated by high-volume surgeon who performed on-pump in > 50% of their cases,
331 off-pump and 285 on-pump patients died in the follow-up period until the end of 2007.
The adjusted HR for death for off-pump compared to on-pump surgery was 1.12 (95% CI:
0.95-1.32, P=0.17).

NIH-PA Author Manuscript

DISCUSSION
In this propensity matched study, we found that the risk of death within 30 days of surgery
was lower for off-pump compared to on-pump surgery and was marginally significant
(HR=0.68, 95% CI: 0.47-0.98), P=0.04), but there was no difference in 7-year mortality
following off-pump and on-pump CABG surgery was found (HR=1.10, 95% CI: 0.99-1.21,
P=0.07). Also, there was a lack of decisive evidence that the difference in 7-year mortality
following these 2 procedures was dependent on the presence of a number of baseline risk
factors.
The observed lower risk of short-term mortality for off-pump surgery is consistent with the
findings of our previous study that examined in-hospital/30-day mortality (adjusted odds
ratio (OR) = 0.81, 95% CI: 0.68-0.97).9 It is also consistent with the findings of a metaanalysis of observational studies by Wijeysundera and colleagues, which reported the OR
for 30-day death was 0.72 (95% CI: 0.66-0.78) for off-pump compared to on-pump surgery.7
In addition, there was a trend that the risk of 30-day death was lower for off-pump surgery
in a meta-analysis of randomized clinical trials, though the difference was not statistically
significant (OR=0.91, 95% CI: 0.45-1.83). 7
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The finding in this study that the difference in 7-year survival between off-pump and onpump surgery was not statistically significant (HR=1.10, 95% CI: 0.99-1.21) is similar to the
findings of other observational studies that examined long-term (≥ 5 years) mortality,
although the findings of other studies varied with regard to statistical significance. In an
observational study of 12,812 patients who underwent procedures in 1997-2006 in 2
hospitals and were followed through March 2007, Puskas and colleagues found nearly
identical results to ours, with no difference in long-term mortality between off-pump and onpump surgery (HR=1.09, 95% CI:0.95-1.25, P=0.23).18 Nonetheless, the observational study
by Puskas et al18 and the current and past studies of our group9, 10 showed a trend of higher
risk of long-term mortality for off-pump surgery, though the P values were either not
significant9, 18 or marginally significant.10 In a single institution observational study that
followed patients for as long as 12 years with a median follow-up of roughly 5 years, Filardo
et al. found that the risk of mortality was significantly higher for off-pump patients
(HR=1.18, 95% CI: 1.02-1.38).19 However, in another observational study consisting of 219
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patients in a single center, Gundry and colleagues reported no difference in 7-year between
off-pump and on-pump surgery (80% vs. 79%, P=0.8).20
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The differences in 5-year or longer-term mortality between the 2 surgical techniques were
also not statistically significant in 4 randomized trials.21-24 Puskas and colleagues found that
the 7-year survival rates for off-pump and on-pump surgery were 83.7% and 73.7%
(P=0.09), respectively, in a randomized trial that enrolled 200 patients.21 In a trial of 281
low-risk patients, van Dijk and colleagues found the 5-year mortality rates between offpump and on-pump surgery was not statistically significant (8.5% vs. 6.5%, P=0.65).22 In
another trial of 308 patients conducted by Hueb and colleagues, the respective 5-year
mortality rates for off-pump and on-pump surgery were 8.4% and 5.2% (P=0.18).23 In a
pooled analysis of 2 trials, using the data of 401 patients in a follow-up period averaging 6
years, Angelini and colleagues found no difference in mortality between off-pump and onpump surgery (HR=1.24, 95% CI: 0.72-2.15, P=0.44).24 However, in a meta-analysis of 11
randomized controlled trials with follow-up ranging from 1 to 6 years22, 24-33, Takagi and
colleagues found that off-pump surgery was associated with increased mortality compared to
on-pump surgery (relative risk=1.37, 95% CI: 1.04-1.81, P=0.02).8
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Thus, none of the long-term studies shows that there is a significantly higher risk of longterm mortality for off-pump surgery, but the meta-analysis suggests that there may be a
survival advantage in favor of on-pump surgery. 8 However, the heterogeneity of the results
of the long-term mortality studies also suggests that there is no definitive data in favor of
long-term survival for either of the 2 surgical techniques.
In addition to examining the overall relative risk of death between off-pump and on-pump
surgery, a subgroup analysis was conducted to test the significance of interactions between
surgery type and a number of baseline risk factors. None of the interaction terms was
statistically significant, therefore, no conclusive evidence was found to support that the
relative risk of death between the 2 procedures is different across subgroups of patients,
even though significant or marginally significant HRs were observed in 4 subgroups of
patients who had ejection fraction at least 40%, were females, had multivessel disease, and
had no congestive heart failure.
When the comparison was limited to the off-pump and on-pump patients who were operated
on by high-volume surgeons who performed more off-pump and on-pump surgery,
respectively, the adjusted HR was 1.12 (P=0.17). Therefore, the result of this sensitivity
analysis was consistent with the overall relative risk of death (HR=1.10, P=0.07).
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A few advantages and limitations of this study are noteworthy when its results are
considered along with other studies. First, a major advantage is that this study is populationbased. This study included all eligible patients treated by any surgeons in any nonfederal
cardiac surgery programs in New York during the study period. Therefore the
generalizability of this study is less likely to be of problem. Second, the rigorous data
collection and validation of the CSRS data ensures the quality of the data. Third, this study
evaluated the relative survival between off-pump and pump CABG surgery in real-world
practice. It can provide useful information complementary to the results of randomized
trials.34, 35
As for limitations, the most important one is that the treatments were not randomized as in
clinical trials. To control for possible treatment selection bias, a propensity matching was
conducted to ensure the baseline risk factors evenly distributed between the matched
patients. Although the possibility of selection bias can not be eliminated with the use of
propensity matching, the propensity analysis improves the validity of this study. Second, to
obtain long-term data on survival, this study had to use the data of patients who underwent
Circ Cardiovasc Qual Outcomes. Author manuscript; available in PMC 2013 January 10.
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procedures a decade ago. Therefore, the improvement in both off-pump and on-pump
CABG surgery over time needs to be considered when the results of this study are
extrapolated in the context of current clinical practice.
In summary, this study found that the difference in 7-year survival between off-pump and
on-pump CABG surgery was not statistically significant. The finding adds more information
to the knowledge on the outcomes of the 2 surgical techniques.
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Figure.

Kaplan-Meier survival curves for propensity matched off-pump and on-pump patients
during 7-year follow-up.
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Table 1

NIH-PA Author Manuscript

Baseline risk factors in the patients.*
Risk Factor
Mean age (yr, mean±SD)

Off-Pump
(N = 2,640)

On-Pump
(N = 5,940)

P-Value

67.7±11.0

65.7±10.5

<0.001

<0.001

Age group (yr) , n (%)
<50

168(6.4)

439(7.4)

50-59

444(16.8)

1,247(21.0)

60-69

742(28.1)

1,853(31.2)

70-79

909(34.4)

1,932(32.5)

≥80

377(14.3)

469(7.9)

787(29.8)

1,660(27.9)

125(4.7)

355(6.0)

Non-Hispanic white

2,274(86.1)

5,050(85.0)

Non-Hispanic black

166(6.3)

287(4.8)

Female sex, n (%)
Race/ethnicity, n (%)

<0.001

Hispanic

NIH-PA Author Manuscript

Non-Hispanic other race

75(2.8)

248(4.2)

Body surface area (m2, mean±SD)

1.98±0.2

2.01±0.2

26(1.0)

42(0.7)

18.5-24.99

708(26.8)

1,345(22.6)

25.0-29.99

1,116(42.3)

2,565(43.2)

30.0-34.99

525(19.9)

1,334(22.4)

35.0-39.99

184(7.0)

453(7.6)

Body mass index

(kg/m2),

0.08

<0.001

n (%)

<18.5

≥40.0
Left main coronary artery disease (stenosis ≥ 50%),
n (%)

81(3.1)

201(3.4)

604(22.9)

1,557(26.2)

488(18.5)

702(11.8)

Number of diseased vessels (stenosis ≥ 70%), n (%)
0 or 1

<0.001

0.001
<0.001

2

808(30.6)

1,744(29.4)

3

1,344(50.9)

3,494(58.8)

Ejection fraction, n (%)

NIH-PA Author Manuscript

<20%

0.05
31(1.2)

101(1.7)

20-29%

185(7.0)

371(6.2)

30-39%

366(13.9)

781(13.1)

40-49%
≥50%
Missing

640(24.2)

1,363(22.9)

1,373(52.0)

3,244(54.6)

45(1.7)

80(1.3)

Previous myocardial infarction, n (%)
≤23 hours before treatment
1-7 days before treatment

0.03
37(1.4)

80(1.3)

374(14.2)

972(16.4)

8-20 days before treatment

172(6.5)

396(6.7)

≥21 days before treatment

815(30.9)

1,666(28.0)
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Risk Factor

NIH-PA Author Manuscript

No previous myocardial infarction

Off-Pump
(N = 2,640)

On-Pump
(N = 5,940)

1,242(47.0)

2,826(47.6)

P-Value

Hemodynamic state, n (%)
Stable
Unstable
Shock

0.59
2,613(99.0)

5,866(98.8)

19(0.7)

56(0.9)

8(0.3)

18(0.3)

0 (0.0)

10 (0.2)

0.04

Cerebrovascular disease, n (%)

549(20.8)

1,034(17.4)

<0.001

Peripheral arterial disease, n (%)

308(11.7)

594(10.0)

0.02

Electrocardiographic evidence of left ventricular
hypertrophy, n (%)

345(13.1)

625(10.5)

<0.001

Cardiopulmonary resuscitation, n (%)

Congestive heart failure, n (%)

<0.001

At current admission

534(20.2)

650(10.9)

Before current admission

147(5.6)

345(5.8)

1,959(74.2)

4,945(83.2)

40(1.5)

91(1.5)

0.95

Chronic obstructive pulmonary disease, n (%)

411(15.6)

1,015(17.1)

<0.001

Extensively calcified ascending aorta, n (%)

177(6.7)

244(4.1)

<0.001

Diabetes, n (%)

833(31.5)

1,922(32.3)

0.46

3(0.1)

2(0.0)

0.16

61(2.3)

72(1.2)

None
Malignant ventricular arrhythmia, n (%)

NIH-PA Author Manuscript

Hepatic failure, n (%)
Renal Failure, n (%)
Requiring dialysis
Creatinine >2.5 mg/dl (220 μmol/liter)

<0.001

65(2.5)

85(1.4)

2,514(95.2)

5,783(97.3)

History of open heart operations, n (%)

194(7.3)

287(4.8)

<0.001

Emergency transfer to operating room after
diagnostic catheterization, n (%)

25(0.9)

90(1.5)

0.04

Emergency transfer to operating room after
percutaneous coronary intervention, n (%)

9(0.3)

33(0.5)

0.19

Percutaneous coronary intervention, this admission,
n (%)

42(1.6)

69(1.2)

0.10

560(21.2)

966(16.3)

<0.001

33(1.3)

83(1.4)

0.59

No renal failure

Percutaneous coronary intervention, before this
admission, n (%)
Stent thrombosis, n (%)

NIH-PA Author Manuscript

*

Plus–minus values are means±SD. Because of rounding, percentages may not total 100.
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Table 2

NIH-PA Author Manuscript

Baseline risk factors in the propensity matched patients.*
Risk Factor
Mean age (yr, mean±SD)

Off-Pump
(N = 2,631)

On-Pump
(N = 2,631)

Standardized
Difference (%)

P-Value

67.7±11.0

67.7±10.7

−0.3

0.90

Age group (yr) , n (%)

0.40

<50

167(6.3)

147(5.6)

3.0

50-59

443(16.8)

457(17.4)

−1.6

60-69

741(28.2)

756(28.7)

−1.1

70-79

908(34.5)

923(35.1)

−1.3

≥80

372(14.1)

348(13.2)

2.6

784(29.8)

771(29.3)

1.1

125(4.8)

121(4.6)

0.9

Non-Hispanic white

2,265(86.1)

2,283(86.8)

−2.0

Non-Hispanic black

166(6.3)

149(5.7)

2.5

Female sex, n (%)
Race/ethnicity, n (%)

0.77

Hispanic

NIH-PA Author Manuscript

Non-Hispanic other race

75(2.9)

78(3.0)

−0.6

Body surface area (m2, mean±SD)

1.98 (0.24)

1.98 (0.24)

−0.4

26(1.0)

25(1.0)

0.0

Body mass index

(kg/m2),

0.69

0.94

n (%)

<18.5
18.5-24.99

703(26.7)

711(27.0)

−0.7

25.0-29.99

1,113(42.3)

1,078(41.0)

2.6

30.0-34.99

524(19.9)

546(20.8)

−2.2

35.0-39.99

184 (7.0)

191(7.3)

−1.2

≥40.0
Left main coronary artery disease (stenosis ≥
50%), n (%)

81(3.1)

80(3.0)

0.6

602(22.9)

623(23.7)

−1.9

Number of diseased vessels (stenosis ≥
70%), n (%)
0 or 1

481(18.3)

0.3

NIH-PA Author Manuscript

2

806(30.6)

808(30.7)

−0.2

3

1,342(51.0)

1,342(51.0)

0.0

31(1.2)

38(1.4)

−1.8

Ejection fraction, n (%)

0.91

20-29%

184(7.0)

182(6.9)

0.4

30-39%

364(13.8)

375(14.3)

−1.4

40-49%
≥50%
Missing

639(24.3)

651(24.7)

−0.9

1,369(52.0)

1,346(51.2)

1.6

44(1.7)

39(1.5)

1.6

Previous myocardial infarction, n (%)
≤23 hours before treatment

0.49
1.00

483(18.4)

<20%

0.80

0.98
36(1.4)

35(1.3)

0.9

1-7 days before treatment

374(14.2)

389(14.8)

−1.7

8-20 days before treatment

171(6.5)

170(6.5)

0.0
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Risk Factor

Off-Pump
(N = 2,631)

NIH-PA Author Manuscript

≥21 days before treatment

On-Pump
(N = 2,631)

Standardized
Difference (%)

810(30.8)

816(31.0)

−0.4

1,240(47.1)

1,221(46.4)

1.4

2,604(99.0)

2,600(98.8)

1.9

Unstable

19(0.7)

19(0.7)

0.0

Shock

8(0.3)

12(0.5)

−3.3

No previous myocardial infarction
Hemodynamic state, n (%)
Stable

P-Value

0.67

0(0)

2(0.1)

−3.8

0.50

Cerebrovascular disease, n (%)

545(20.7)

546(20.8)

−0.2

0.97

Peripheral arterial disease, n (%)

305(11.6)

309(11.7)

−0.3

0.86

Electrocardiographic evidence of left
ventricular hypertrophy, n (%)

341(13.0)

331(12.6)

1.2

0.68

526(20.0)

482(18.3)

4.3

Cardiopulmonary resuscitation, n (%)

Congestive heart failure, n (%)
At current admission
Before current admission
None
Malignant ventricular arrhythmia, n (%)

NIH-PA Author Manuscript

Chronic obstructive pulmonary disease, n (%)

0.29

147(5.6)

145(5.5)

0.4

1,958(74.4)

2,004(76.2)

−4.2

40(1.5)

46(1.7)

−1.6

0.51

410(15.6)

441(16.8)

−3.3

0.25

Extensively calcified ascending aorta, n (%)

175(6.7)

166(6.3)

1.6

0.61

Diabetes, n (%)

831(31.6)

814(30.9)

1.5

0.61

3(0.1)

2 (0.1)

0.8

0.65

Hepatic failure, n (%)
Renal Failure, n (%)

0.41

Requiring dialysis

60(2.3)

53(2.0)

2.1

Creatinine >2.5 mg/dl (220 μmol/liter)

63(2.4)

51(1.9)

3.4

2,508(95.3)

2,527(96.0)

−3.4

History of open heart operations, n (%)

190(7.2)

179(6.8)

1.6

0.55

Emergency transfer to operating room after
diagnostic catheterization, n (%)

25(1.0)

25(1.0)

0.0

1.00

Emergency transfer to operating room after
percutaneous coronary intervention, n (%)

9(0.3)

11(0.4)

−1.6

0.65

Percutaneous coronary intervention, this
admission, n (%)

41(1.5)

37(1.4)

1.7

0.65

555(21.1)

546(20.8)

0.7

0.76

33(1.3)

32(1.2)

0.9

0.90

No renal failure

Percutaneous coronary intervention, before
this admission, n (%)

NIH-PA Author Manuscript

Stent thrombosis, n (%)
*

Plus–minus values are means±SD. Because of rounding, percentages may not total 100.
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162/305
620/2,326

574/2,322

151/309

487/2,085

539/2,086

No

238/546

Yes

Peripheral arterial disease

No

Yes

269/1,221

456/1,410

243/545

306/1,240

Cerebrovascular disease

476/1,391

454/1,997

534/2,008

No

258/595

Yes

Previous myocardial infarction

40%+

<40%

103/481

622/2,150

234/579

103/483

Ejection fraction

679/2,148

523/2,008

559/2,029

0, 1

202/623

2, 3

Number of diseased vessels

No

Yes

480/1,860

245/771

188/348

302/923

165/756

70/604

On-Pump

223/602

273/784
509/1,847

210/372

80+

Male

326/908

70-79

Female

163/741

60-69

Left main coronary disease

Sex

83/610

Off-Pump

<60

Age (yr)

Patient Group

No. of Deaths/Total Cases

74.2

47.5

75.1

56.0

75.9

66.9

74.4

60.3

80.1

69.1

73.2

64.3

73.4

65.9

45.4

65.1

78.8

86.6

76.1

52.4

77.4

57.7

78.5

68.8

78.0

58.0

79.2

72.0

74.8

68.5

75.1

69.1

46.8

68.1

79.1

89.2

0.13

0.25

0.07

0.58

0.12

0.26

0.003

0.26

0.92

0.04

0.25

0.10

0.23

0.17

0.42

0.13

0.92

0.32

1.09(0.97,1.22)

1.15(0.91,1.45)

1.12(0.99,1.27)

1.05(0.87,1.27)

1.08(0.92,1.27)

1.12(0.97,1.28)

1.18(1.04,1.34)

0.95(0.79,1.15)

0.94(0.71,1.24)

1.13(1.01,1.26)

1.07(0.95,1.21)

1.18(0.97,1.44)

1.05(0.93,1.19)

1.21(1.01,1.45)

1.13(0.92,1.38)

1.14(0.97,1.34)

0.98(0.79,1.22)

1.16(0.85,1.58)

0.15

0.23

0.06

0.59

0.33

0.11

0.01

0.62

0.66

0.03

0.26

0.10

0.44

0.04

0.24

0.12

0.86

0.35

P-value

Hazard Ratio
(95% CI)

PValue

OffPump

OnPump

Adjusted Hazard Ratio for
Death (Off- vs. On-Pump) †

7-year KM Survival (%)

0.67

0.57

0.79

0.07

0.22

0.42

0.22

0.69

P-Value
for
Interaction

Subgroup-specific hazard ratios for death after off-pump CABG surgery as compared with on-pump surgery.*
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306/673

306/831
476/1,800

No

476/1,958

Yes

Diabetes

No

Yes

Congestive heart failure

Off-Pump

435/1,817

290/814

424/2,004

301/627

On-Pump

74.6

63.7

76.7

55.0

76.7

65.8

79.3

54.2

0.09

0.51

0.02

0.46

PValue

1.11(0.97,1.26)

1.09(0.93,1.29)

1.16(1.02,1.32)

1.02(0.86,1.21)

0.14

0.29

0.03

0.81

P-value

Hazard Ratio
(95% CI)

OnPump

OffPump

0.92

0.25

P-Value
for
Interaction

Risk factors adjusted for included age, race/ethnicity, ejection fraction, left main coronary disease, cerebrovascular disease, peripheral arterial disease, congestive heart failure, chronic obstructive
pulmonary disease, diabetes, and renal failure.

†
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Patient Group

Adjusted Hazard Ratio for
Death (Off- vs. On-Pump) †
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7-year KM Survival (%)
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